After establishing the novel finding that miR18a is regulated by ECM parameters in a glioma cell line, we next wanted to quantitatively understand the regulation of miR18a expression as a function of fibronectin density and substrate stiffness. The gene discussed is FN1; the disease is central nervous system cancer.